Abstract:Alzheimer’s disease (AD) is a rapidly growing public health concern with potentially devastating effects. Presently, there are no known cures or effective preventive strategies. While genetic factors are relevant in early-onset cases, they appear to play less of a role in late-onset sporadic AD cases, the most common form of AD. Due to the fact that the disease typically strikes very late in life, delaying symptoms could be as good as a cure for many people. For example, it is now widely accepted that if the onset of the disease could be delayed by even 5 years, the incidence could be cut in half. Both clinical and epidemiological evidence suggests that modification of lifestyle factors such as nutrition may prove crucial to AD management given the mounting experimental evidence suggesting that brain cells are remarkably responsive to ‘what somebody is doing’. Among other nongenetic factors influencing AD, recent studies strongly support the evidence that caloric intake may play a role in the relative risk for AD clinical dementia. Indeed, the effect of diet in AD has been an area of research that has produced promising results, at least experimentally. Most importantly, as mechanistic pathways are defined and their biochemical functions scrutinized, the evidence supporting a direct link between nutrition and AD neuropathology continues to grow. Our work, as well as that of others, has recently resulted in the development of experimental dietary regimens that might promote, attenuate or even reverse features of AD. Most remarkably, while we found that high caloric intake based on saturated fat promotes AD type Β-amyloidosis, conversely we found that dietary restriction based on reduced carbohydrate intake is able to prevent it. This evidence is very exciting and is, in part, consistent with current epidemiological studies suggesting that obesity and diabetes are associated with a >4-fold increased risk of developing AD. The clarification of the mechanisms through which dietary restriction may beneficially influence AD neuropathology and the eventual discovery of future ‘mimetics’ capable of anti-Β-amyloidogenic activity will help in the development of ‘lifestyle therapeutic strategies’ in AD and possibly other neurodegenerative disorders.

Calorie Restriction Attenuates Alzheimer'S Disease Type Brain Amyloidosis in Squirrel Monkeys (saimiri Sciureus)

Neuronal SIRT1 Activation As a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction.

Caloric Restriction Attenuates Β‐amyloid Neuropathology in a Mouse Model of Alzheimer's Disease

Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy

Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome

Caloric Restriction Improves Spatial Learning Deficits in Tau Mice

Rhesus monkeys as a translational model for late‐onset Alzheimer's disease

Long-term calorie restriction reduces oxidative DNA damage to oligodendroglia and promotes homeostatic microglia in the aging monkey brain

Regulation of Forkhead Transcription Factor Foxo3a Contributes to Calorie Restriction-Induced Prevention of Alzheimer'S Disease-Type Amyloid Neuropathology and Spatial Memory Deterioration

Restriction of dietary protein slows the development and progression of Alzheimer’s disease in 3xTg mice

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): metabolic, physiologic, and atherosclerotic measures from a 4-year intervention trial.

Caloric restriction ameliorates acrolein-induced neurotoxicity in rats.

Neurodegeneration: Effects of Calorie Restriction on the Brain Sirtuin Protein Levels

The Effects of Caloric Restriction and Its Mimetics in Alzheimer's Disease Through Autophagy Pathways

Endocrine Effects of Dietary Restriction and Aging: The National Institute on Aging Study

Bearded capuchin monkeys as a model for Alzheimer's disease

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease

Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide

Caloric Intake and Alzheimer’s Disease

Aged rhesus monkeys: Cognitive performance categorizations and preclinical drug testing